BAX Stock Analysis: Buy, Sell, or Hold?

BAX - Baxter International Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$26.34
-0.07 (-0.27%) â–ŧ
5d: -1.46%
30d: +21.55%
90d: +38.41%
WAIT
LOW Confidence
Protect Your BAX Gains
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 30, 2026 0d
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Aug 17, 2026 at $25.91 · last confirmed Aug 19, 2026

Strength: 7.5/10

Get Alerted When BAX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: BAX is fairly priced but lacks strong directional signals. At 10.4% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$4.17
Based on -23.9% avg growth
INTRINSIC VALUE TODAY
$2.59
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BAX is currently trading at $26.34, which is considered slightly high relative to its 30-day fair value range of $22.85 to $27.40. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.9) compared to its historical average (9.6). At these levels, the market is pricing in 10.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, BAX is in a strong uptrend. The price is currently testing key support at $25.75. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: BAX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $22.85 - $27.40
Company Quality Score 40/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 37.1%

Protect Your Profits

Holding BAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Weak technical setup (30/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($28.73)
  • NEUTRAL: Trading at premium valuation - market expects 10.4% growth which is achievable
  • WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $22.85 - $27.40
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $25.75
Resistance Level $28.02
Current Trend Strong Uptrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 12.93
Wall Street Target $28.73 (+9.1%)
Revenue Growth (YoY) 5.3%
Earnings Growth (YoY) 36.8%
Profit Margin -9.3%
Valuation Premium vs History +10.4% premium
PE vs Historical 12.9 vs 9.6 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +10.4% (market-implied from PE analysis)
1-Year Target $29.08 (+10%)
2-Year Target $32.10 (+22%)
3-Year Target $35.44 (+35%)
3-Yr Target (if PE normalizes) (PE: 13→10) PE COMPRESSION $26.31 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.1, Growth: -51.8%) $40.24 (+53%)
Base: (SPY PE: 12.9, Growth: -51.8%) $25.93 (-2%)
Bear: (PE: 9.6, Growth: -51.8%) $19.25 (-27%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 22, 2026 1:17 PM ET
Data refreshes hourly during market hours. Next update: 2:17 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BAX.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$478 46 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$86 37 SELL
WST
West Pharmaceutical Servâ€Ļ
STRONG BUY
13 analysts
$405 66 BUY
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$186 45 HOLD
RMD
ResMed Inc
BUY
19 analysts
$247 41 HOLD

Advanced BAX Option Strategies

Professional options setups generated by AI based on today's BAX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BAX

BAX Technical Chart BAX Price Prediction BAX Earnings Date BAX Investment Advisor BAX Fair Price Analyzer BAX Options Advisor BAX Options Chain BAX Options Analysis BAX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals